glp-1 news november 6 2025 🚨 Breaking in Obesity Care! 🚨 President Trump just announced major deals with Eli Lilly and Novo Nordisk — the makers of Mounjaro, Zepbound, Wegovy, and Ozempic — to slash weight Stopping and restarting GLP-1s may

Description

Efficacy, safety, and tolerability of exenatide once weekly in patients with type 2 diabetes mellitus: An integrated analysis of the DURATION trials

Reduced Appetite: GLP-1 can lower hunger levels by affecting the brains appetite control centers

Though delayed gastric emptying and GI side effects of GLP-1 RAs are tempting explanations for the weight loss, their correlation with weight loss in diabetic patients was contradicted by several clinical trials [128, 129]

Weekly glucagon-like peptide-1 receptor agonist albiglutide as monotherapy improves glycemic parameters in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled study